Conference Menu

Current Event

Overview
Register
Day 1
Day 2
Day 3
Short Course
Hotel & Travel
PDF Download
Sponsor/Exhibit
Posters
Press Pass
Request Brochure
Archives

DVD logo

Evidence Led Decision Making
for Clinical Proof-of-Concepts

Accelerating Proof of Concept


	Conference Proceeding CD Now Available Single Copy - $350.00Site License - $995.00	Speaker Presentations Poster Abstracts and More!

KEYNOTE ADDRESS Kenneth Kaitin

Getting to ‘No’: Accelerating Proof of Concept to Speed Development and Manage Risk

Kenneth I. Kaitin, Ph.D., Director, Tufts Center for the Study of Drug Development

SESSION TOPICS

Preclinical & Early Development to Reduce Attrition
Biomarkers & Pharmacogenomics:
Early Phase Development Acceleration
Proof-of-Concept: Science to Strategy
Innovative & Adaptive Clinical Trial Design
Case Studies

FEATURED SPEAKERS

Walter Janssens, Ph.D., Senior Preclinical Assessor, Preauthorisation, Coordinator Early Phase Development, Federal Agency for Medicines and Health Products

Chris H. Takimoto, M.D., Ph.D., Senior Director, Translational Medicine, Ortho Biotech Oncology R&D/Centocor R&D, Inc.

Coreen Oei, Ph.D., Vice President, Scientific & Clinical Operations, GlaxoSmithKline

Joseph C. Fleishaker, Ph.D., FAAPS, FCP, VP, PGRD, St. Louis Laboratories, Clinical Research, Pfizer Inc.

Thierry Sornasse, Ph.D., Director, Translational Medicine, Biomarker Integration, Elan Pharmaceuticals, Inc.

Martin Wehling, M.D., Managing Director, Institute for Experimental and Clinical Pharmacology and Toxicology,
Director, Clinical Pharmacology Mannheim Medical Faculty, Mannheim Ruprecht-Karls-University Heidelberg

SHORT COURSE

Evidence Led Decision Making for Clinical Proof-of-Concepts